Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

2015376 citationsJournal Articlehybrid Open Access

Authors

The LUTE study was registered under NCT01545440 and the VERSE study under NCT01545453 at http://www.clinicaltrials.gov.

Good health and well-being

Published in: Thorax

Volume 70, Issue 8, pp. 748-756

Field-Weighted Citation Impact: 40.42